ClinConnect ClinConnect Logo
Search / Trial NCT06883565

Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study

Launched by DING-WEI YE · Mar 13, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients diagnosed with renal cell carcinoma
  • Exclusion Criteria:
  • incomplete medical records, inadequate follow-up information, and confirmed non-prostatic acinar adenocarcinoma

About Ding Wei Ye

Ding-Wei Ye is a distinguished clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodologies and ethical standards, the organization collaborates with leading researchers and healthcare professionals to conduct high-quality clinical trials across various therapeutic areas. Ding-Wei Ye emphasizes transparency, patient safety, and regulatory compliance, ensuring that each study contributes valuable insights to the medical community. Their dedication to fostering partnerships and driving advancements in healthcare positions them as a key player in the evolution of clinical research.

Locations

Shanghai, , China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported